Search

Sloan Kettering Institute investigators are taking important steps toward being able to identify all the cell types in tumors. With this information, they can figure out how the cells work together.

… Thursday, June 28, 2018 Summary Sloan Kettering Institute investigators are laying the groundwork for research into the different cell types in found in and around tumors. The composition of malignant tumors is incredibly complex. They contain not only cancer cells but also dozens of other cell types

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.

… Saturday, December 8, 2012 Summary Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer. President Barack Obama announced on December 6 his intent to appoint Memorial Sloan

Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and highest-caliber cancer care.

… Tuesday, August 4, 2015 Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and highest-caliber cancer

Dana Pe’er, PhD, computational biologist and lab head at Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), is one of 33 biomedical researchers named a Howard Hughes Medical Institute (HHMI) investigator today.

… Thursday, September 23, 2021 Dana Pe’er, PhD , computational biologist and lab head at Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), is one of 33 biomedical researchers named a Howard Hughes Medical Institute (HHMI) investigator today. The elite group of scientists,

An enzyme that contributes to plaque formation in the brain also serves as a first line of defense against bacteria and viruses, suggesting a link between the two.

… Wednesday, September 2, 2020 Summary Scientists at the Sloan Kettering Institute have discovered a direct link between the immune response to viruses and bacteria and the development of plaques in the brain that characterize Alzheimer’s disease. Alzheimer’s disease is a neurodegenerative condition that

Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.

… Friday, July 11, 2014 Summary Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it. The word “transformation” perfectly characterizes and captures the past year at Memorial Sloan Kettering. Indeed, it’s the word we

Cancer often leaves those it touches consumed with a feeling of hopelessness. But sometimes that feeling can motivate clinicians, patients, and supporters alike to turn soul-crushing moments into positive change.

… Thursday, January 27, 2022 Cancer often leaves those it touches consumed with a feeling of hopelessness. But sometimes that feeling can motivate clinicians, patients, and supporters alike to turn soul-crushing moments into positive change. Dave Linn and Jennifer Goodman Linn used their experience with

The drug, sotorasib, is targeted against a cancer-causing protein that has long been considered an “undruggable” target.

… Sunday, September 20, 2020 Summary In a study of people with lung cancer whose tumors contained the mutation targeted by sotorasib, 52 of 59 patients experienced disease control, which means that their tumors stopped growing. Update: On January 30, 2021, Memorial Sloan Kettering lung cancer expert Bob

A new tool developed by MSK scientists allows users to map metabolic data from kidney cancer tumors.

… Friday, February 5, 2016 Summary Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may

Awarded annually since 1955, the Sloan Research Fellowships honor exceptional U.S. and Canadian researchers whose creativity, leadership, innovation, and research accomplishments make them stand out as the next generation of leaders.

… Thursday, February 22, 2024 Memorial Sloan Kettering Cancer Center (MSK)  is proud to announce that  Yael David, PhD , chemical biologist leading The Yael David Lab and Associate Member of the Chemical Biology Program , has been selected as a 2024 Alfred P. Sloan Research Fellow in Chemistry. Dr. David